2024-10-28 16:20:07
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with Chemotherapy as First-Line Therapy for Esophageal Squamous Cell Carcinoma (ESCC)
Corporate/ 2023-07-23
Innovent Announces NMPA Acceptance of a ...

SAN FRANCISCO and SUZHOU,China,Sept. 23,2021-- Innovent Biologics,Inc. (Innovent) (HKEX: 01801),a world-class biopharmaceutical company that...

MedAlliance announces completion of enrollment in Japanese SELUTION SLR™ Study
Health/ 2023-07-22
MedAlliance announces completion of enro...

GENEVA,Sept. 23,2021--MedAlliance,with its Japanese partner MDK Medical,has completed enrollment in the clinical study of its novelSirolimus...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release